<html><head><title>GSE217300</title></head>
<body>
<h1>GSE217300</h1>
<img src="png/GSE217300.png" style="float:right;width:600px;height:400px;">
<li>Series_title: Exposure to a bacterial metabolite induces specific transcriptional signature of DAF-16 regulated genes, xanthine oxidase, and Phase I detoxification enzymes in C. elegans
<li>Series_summary: RNA-seq analysis of the effect of a secondary metabolite produced by Streptomyces venezuelae that enhanced oxidative stress, mitochondrial dysfunction, and neurodegeneration in Caenorhabditis elegans. #-# Nearly all DEGs had previous evidence of an association with DAF-16 (FOXO). DEGs were also enriched for Phase I (CYP) and Phase II (UGT) detoxification genes. #-# DEGs representing several non-CYP Phase I enzymes were identified, including down-regulation of xdh-1. XDH-1 is interconvertible with XO and S. ven metabolite exposure enhanced XO activity.
<li>Series_overall_design: Comparative gene expression profiling analysis of RNA-seq data for C. elegans exposed to the S.ven metabolite or an ethyl acetate solvent control, 5 biological replicates.
<li>Series_type: Expression profiling by high throughput sequencing
<dl><dt>C1</dt>
<dd><b>GSM6710675</b> BY250 strain, S.ven treatment, day 5, rep3 | whole animal | whole animal | GFP overexpression</dd>
<dd><b>GSM6710685</b> BY250 strain, S.ven treatment, day 7, rep3 | whole animal | whole animal | GFP overexpression</dd>
<dd><b>GSM6710690</b> BY250 strain, EtAc treatment, day 7, rep3 | whole animal | whole animal | GFP overexpression</dd>
<dd><b>GSM6710680</b> BY250 strain, EtAc treatment, day 5, rep3 | whole animal | whole animal | GFP overexpression</dd>
</dl>
<dl><dt>C2</dt>
<dd><b>GSM6710678</b> BY250 strain, EtAc treatment, day 5, rep1 | whole animal | whole animal | GFP overexpression</dd>
<dd><b>GSM6710673</b> BY250 strain, S.ven treatment, day 5, rep1 | whole animal | whole animal | GFP overexpression</dd>
<dd><b>GSM6710688</b> BY250 strain, EtAc treatment, day 7, rep1 | whole animal | whole animal | GFP overexpression</dd>
<dd><b>GSM6710683</b> BY250 strain, S.ven treatment, day 7, rep1 | whole animal | whole animal | GFP overexpression</dd>
</dl>
<dl><dt>C3</dt>
<dd><b>GSM6710676</b> BY250 strain, S.ven treatment, day 5, rep4 | whole animal | whole animal | GFP overexpression</dd>
<dd><b>GSM6710691</b> BY250 strain, EtAc treatment, day 7, rep4 | whole animal | whole animal | GFP overexpression</dd>
<dd><b>GSM6710686</b> BY250 strain, S.ven treatment, day 7, rep4 | whole animal | whole animal | GFP overexpression</dd>
<dd><b>GSM6710681</b> BY250 strain, EtAc treatment, day 5, rep4 | whole animal | whole animal | GFP overexpression</dd>
</dl>
<dl><dt>C4</dt>
<dd><b>GSM6710682</b> BY250 strain, EtAc treatment, day 5, rep5 | whole animal | whole animal | GFP overexpression</dd>
<dd><b>GSM6710692</b> BY250 strain, EtAc treatment, day 7, rep5 | whole animal | whole animal | GFP overexpression</dd>
<dd><b>GSM6710687</b> BY250 strain, S.ven treatment, day 7, rep5 | whole animal | whole animal | GFP overexpression</dd>
<dd><b>GSM6710677</b> BY250 strain, S.ven treatment, day 5, rep5 | whole animal | whole animal | GFP overexpression</dd>
</dl>
<dl><dt>C5</dt>
<dd><b>GSM6710684</b> BY250 strain, S.ven treatment, day 7, rep2 | whole animal | whole animal | GFP overexpression</dd>
<dd><b>GSM6710689</b> BY250 strain, EtAc treatment, day 7, rep2 | whole animal | whole animal | GFP overexpression</dd>
<dd><b>GSM6710674</b> BY250 strain, S.ven treatment, day 5, rep2 | whole animal | whole animal | GFP overexpression</dd>
<dd><b>GSM6710679</b> BY250 strain, EtAc treatment, day 5, rep2 | whole animal | whole animal | GFP overexpression</dd>
</dl>
</body>
</html>
